FDA Approves AstraZeneca's Imjudo for Combination Liver Cancer Treatment - PharmTech

Retrieved on: 2022-10-26 21:07:48

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves AstraZeneca's Imjudo for Combination Liver Cancer Treatment - PharmTech. View article details on hiswai:

Excerpt

AstraZeneca's Imjudo (tremelimumab) was approved by FDA in combination with Imfinzi (durvalumab) for treating unresectable liver cancer.

Article found on: www.pharmtech.com